Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States.

Rice JB, White AG, Galebach P, Korenblat KM, Wagh A, Lovelace B, Wan GJ, Jamil K.

Curr Med Res Opin. 2017 Aug;33(8):1473-1480. doi: 10.1080/03007995.2017.1331211. Epub 2017 Jun 2.

PMID:
28509578
2.

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.

Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, Teperman L, Fontana R, Schiff E, Fried M, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS Jr, Charlton M; ASTRAL-4 Investigators.

N Engl J Med. 2015 Dec 31;373(27):2618-28. doi: 10.1056/NEJMoa1512614. Epub 2015 Nov 16.

3.

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.

Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS Jr, Fried MW, Terrault NA, O'Leary JG, Vargas HE, Kuo A, Schiff E, Sulkowski MS, Gilroy R, Watt KD, Brown K, Kwo P, Pungpapong S, Korenblat KM, Muir AJ, Teperman L, Fontana RJ, Denning J, Arterburn S, Dvory-Sobol H, Brandt-Sarif T, Pang PS, McHutchison JG, Reddy KR, Afdhal N; SOLAR-1 Investigators.

Gastroenterology. 2015 Sep;149(3):649-59. doi: 10.1053/j.gastro.2015.05.010. Epub 2015 May 15.

4.

Liver volume in the cirrhotic patient: does size matter?

Hagan MT, Sayuk GS, Lisker-Melman M, Korenblat KM, Kerr TA, Chapman WC, Crippin JS.

Dig Dis Sci. 2014 Apr;59(4):886-91. doi: 10.1007/s10620-014-3038-1. Epub 2014 Feb 7.

5.

Circulating miR-122 as a potential biomarker of liver disease.

Laterza OF, Scott MG, Garrett-Engele PW, Korenblat KM, Lockwood CM.

Biomark Med. 2013 Apr;7(2):205-10. doi: 10.2217/bmm.12.107.

PMID:
23547815
6.

Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver.

Hall AM, Kou K, Chen Z, Pietka TA, Kumar M, Korenblat KM, Lee K, Ahn K, Fabbrini E, Klein S, Goodwin B, Finck BN.

J Lipid Res. 2012 May;53(5):990-9. doi: 10.1194/jlr.P025536. Epub 2012 Mar 6.

7.

MicroRNAs and liver disease.

Kerr TA, Korenblat KM, Davidson NO.

Transl Res. 2011 Apr;157(4):241-52. doi: 10.1016/j.trsl.2011.01.008. Epub 2011 Feb 2. Review.

8.

Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.

Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, Klein S.

J Clin Endocrinol Metab. 2010 Jun;95(6):2727-35. doi: 10.1210/jc.2009-2622. Epub 2010 Apr 6.

9.

Persistent increase in aspartate aminotransferase in an asymptomatic patient.

Krishnamurthy S, Korenblat KM, Scott MG.

Clin Chem. 2009 Aug;55(8):1573-5. doi: 10.1373/clinchem.2008.120782. No abstract available.

10.

Long-term management of the liver transplant patient: recommendations for the primary care doctor.

McGuire BM, Rosenthal P, Brown CC, Busch AM, Calcatera SM, Claria RS, Hunt NK, Korenblat KM, Mazariegos GV, Moonka D, Orloff SL, Perry DK, Rosen CB, Scott DL, Sudan DL; American Society of Transplantation.

Am J Transplant. 2009 Sep;9(9):1988-2003. doi: 10.1111/j.1600-6143.2009.02733.x. Epub 2009 Jun 26.

11.

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Korenblat KM, Fabbrini E, Mohammed BS, Klein S.

Gastroenterology. 2008 May;134(5):1369-75. doi: 10.1053/j.gastro.2008.01.075. Epub 2008 Jan 30.

12.

Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S.

Gastroenterology. 2008 Feb;134(2):424-31. doi: 10.1053/j.gastro.2007.11.038. Epub 2007 Nov 28.

13.

Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss.

Croce MA, Eagon JC, LaRiviere LL, Korenblat KM, Klein S, Finck BN.

Diabetes. 2007 Sep;56(9):2395-9. Epub 2007 Jun 11.

14.

Disseminated histoplasmosis in a liver transplant recipient.

Oh YS, Lisker-Melman M, Korenblat KM, Zuckerman GR, Crippin JS.

Liver Transpl. 2006 Apr;12(4):677-81.

15.

Patient and graft outcomes following liver transplantation for sarcoidosis.

Lipson EJ, Fiel MI, Florman SS, Korenblat KM.

Clin Transplant. 2005 Aug;19(4):487-91.

PMID:
16008593
16.

Hyperbilirubinemia in the setting of antiviral therapy.

Korenblat KM, Berk PD.

Clin Gastroenterol Hepatol. 2005 Apr;3(4):303-10. Review.

PMID:
15822033
17.

Inherited metabolic liver disease.

Korenblat KM, Schilsky ML.

Curr Opin Gastroenterol. 2003 May;19(3):194-202. No abstract available.

PMID:
15703560
18.

A yeast artificial chromosome contig from human chromosome 14q24 spanning the Alzheimer's disease locus AD3.

Clark RF, Cruts M, Korenblat KM, He C, Talbot C, Van Broeckhoven C, Goate AM.

Hum Mol Genet. 1995 Aug;4(8):1347-54.

PMID:
7581373

Supplemental Content

Loading ...
Support Center